Email Updates

You are here

AVAC in the News

  • Even if a jab is shown to work, there won’t be enough doses for everyone. Countries such as South Africa would need to make tough decisions about who it would give the vaccine to — and more importantly how to create a system to get it to them.

    October 14, 2020
    General
    Bhekisisa
  • Experts have called on the federal government and other stakeholders to invest more in efforts to prevent HIV infection human immunodeficiency virus, HIV prevention interventions while advocating for supportive policy and programmes.

    October 13, 2020
    Vanguard
  • A coalition of NGOS on Monday urged the Federal Government to utilise diverse popular culture (pop culture) as avenues to create awareness and sensitise youths on HIV/AIDS prevention. The NGOs made the call during an online discussion on the role of media in HIV prevention advocacy’’, organised by the AVAC in collaboration with Journalists Against AIDS Nigeria (JAAIDS).

    October 6, 2020
    The Guardian Nigeria
  • COVID-19 has devastated communities and health systems around the world — but it has also created an historic global effort leading to the unprecedented development of more than 165 potential vaccines against COVID-19. Equally impressive innovations are speeding vaccine testing within a rigorous scientific framework, while manufacturing and transportation capacity are being scaled up to distribute millions of doses of future COVID vaccines to those who need them most.

    September 30, 2020
    General
    POZ
  • COVID-19 has devastated communities and health systems around the world – but it has also created an historic global effort leading to the unprecedented development of more than 165 potential vaccines against COVID-19. Equally impressive innovations are speeding vaccine testing within a rigorous scientific framework, while manufacturing and transportation capacity are being scaled up to distribute millions of doses of future COVID vaccines to those who need them most.

    September 24, 2020
    General
    Science Speaks
  • With hundreds of potential COVID vaccine candidates being tested around the world, here’s a quick guide to which ones you should keep an eye on — and when we could see results.

    September 17, 2020
    General
    Bhekisisa
  • Standardized metrics and data collection aid meaningful comparisons of optimal community engagement methods for trial enrollment. Internet strategies had better success in the Americas/Switzerland than in sub-Saharan African countries. Data are essential in outreach staff efforts to improve screening-to-enrollment ratios.

    September 17, 2020
    General
    PLOS One
  • One of South Africa’s three COVID-19 vaccine trials was recently put on hold after a participant in the United Kingdom developed an unexplained illness. After an independent review, AstraZeneca’s candidate, which was considered to be a frontrunner in the field, is expected to resume locally this week. But results are still a long shot for this year, says the trial’s lead investigator.

    September 15, 2020
    General
    Bhekisisa
  • Maureen Luba is the Africa Region Advocacy Advisor at AIDS Vaccine Advocacy Coalition (AVAC) where she helps lead capacity building efforts around strategy development, data analytics and use for advocacy for Civil Society Organizations in Zimbabwe, Tanzania and Malawi to effectively engage in Global Fund, PEPFAR and national policy decision-making processes. She graduated from the University of Malawi with a Bachelor’s Degree in Public Administration.

    September 10, 2020
    General
    BMJ Leader
  • The California law allowing pharmacists to prescribe HIV prevention medication has encouraged lawmakers around the country to pass similar measures to reduce hurdles and expand access to pre-exposure prophylaxis (PrEP). With the passage of Senate Bill 159, California became the first state in the nation to allow pharmacists to provide PrEP and post-exposure prophylaxis (PEP).

    September 10, 2020
    The BodyPro

Pages